References
Original article
Luo, W. et al. Remyelination in neuromyelitis optica spectrum disorder is promoted by edaravone through mTROC1 signaling activation. Glia https://doi.org/10.1002/glia.24271 (2022)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lempriere, S. FDA-approved drug promotes remyelination. Nat Rev Neurol 18, 637 (2022). https://doi.org/10.1038/s41582-022-00729-3
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41582-022-00729-3
- Springer Nature Limited